BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38266271)

  • 1. Mycophenolate mofetil inhibits Merkel cell carcinoma growth.
    Garman KA; Thoreson N; Strong J; Hallaert P; Gelb T; Shen M; Hall MD; Brownell I
    Br J Dermatol; 2024 Mar; 190(4):593-595. PubMed ID: 38266271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil.
    Sievers TM; Rossi SJ; Ghobrial RM; Arriola E; Nishimura P; Kawano M; Holt CD
    Pharmacotherapy; 1997; 17(6):1178-97. PubMed ID: 9399601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mycophenolate mofetil, a possible new immunosuppresant].
    Weberová J; Voboril R; Semecký V
    Ceska Slov Farm; 2002 Sep; 51(5):220-5. PubMed ID: 12407919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive activity of mycophenolate mofetil.
    Eugui EM; Allison AC
    Ann N Y Acad Sci; 1993 Jun; 685():309-29. PubMed ID: 8363235
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B; Markham A
    Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil: a unique immunosuppressive agent.
    Hood KA; Zarembski DG
    Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T
    Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.
    Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA
    Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 11. Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection.
    Sanford M; Keating GM
    Drugs; 2008; 68(17):2505-33. PubMed ID: 19016576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
    Simmons WD; Rayhill SC; Sollinger HW
    Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience.
    Kirklin JK; Bourge RC; Naftel DC; Morrow WR; Deierhoi MH; Kauffman RS; White-Williams C; Nomberg RI; Holman WL; Smith DC
    J Heart Lung Transplant; 1994; 13(3):444-50. PubMed ID: 8061021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mycophenolate mofetil: a new approach by immunosuppressive treatment].
    Thervet E
    Pathol Biol (Paris); 2001 Feb; 49(1):9-11. PubMed ID: 11265229
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms of action of mycophenolate mofetil in preventing chronic rejection.
    Allison AC
    Transplant Proc; 2002 Nov; 34(7):2863-6. PubMed ID: 12431636
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil in kidney transplantation.
    Lui SL; Halloran PF
    Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):508-13. PubMed ID: 8978998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil in the prevention of rejection after kidney transplantation.
    Kiehl MG
    Transplantation; 2000 Apr; 69(8):1753-4. PubMed ID: 10836400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.